Meng-Ting Li

5PUBLICATIONS
2CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Cross-sectional analysisImmunogenetics (incl. genetic immunology)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 08, 2026
Correlation between severity of myelosuppression caused by piperacillin-tazobactam and factors: Analysis through a multivariate ordered logistic regression mode.

|Oct 15, 2025
Nab-paclitaxel vs paclitaxel liposome for advanced breast cancer: real-world efficacy and safety analysis.

Meng-Ting Li, Ji-Sheng Chen

|Aug 26, 2025
Paclitaxel-based strategy as first-line therapy for advanced breast cancer: a model-based economic evaluation for China.

Ji-Sheng Chen, Jia Hu, Meng-Ting Li

|Jan 22, 2024
Clinical characteristics, diagnosis and management of nivolumab-induced myocarditis.

Meng-Ting Li, Yang He, Si-Yong Huang

|Nov 01, 2022
Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis.

Meng-Ting Li, Jia Wang, Jia Hu

Pageof 1

Frequent Collaborators

3 joint publications

Ji-Sheng Chen

1 joint publications

Wei-Shang Deng